Corient Private Wealth’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.2M | Sell |
1,051,304
-73,114
| -7% | -$5.02M | 0.08% | 207 |
|
|
2025
Q1 | $78.1M | Sell |
1,124,418
-152,292
| -12% | -$10.6M | 0.13% | 167 |
|
|
2024
Q4 | $107M | Sell |
1,276,710
-120,864
| -9% | -$10.1M | 0.18% | 123 |
|
|
2024
Q3 | $166M | Buy |
1,397,574
+7,983
| +0.6% | +$951K | 0.26% | 87 |
|
|
2024
Q2 | $198M | Buy |
1,389,591
+88,599
| +7% | +$12.6M | 0.35% | 59 |
|
|
2024
Q1 | $167M | Buy |
1,300,992
+52,777
| +4% | +$6.78M | 0.3% | 75 |
|
|
2023
Q4 | $129M | Buy |
1,248,215
+411,907
| +49% | +$42.6M | 0.24% | 97 |
|
|
2023
Q3 | $76.1M | Buy |
836,308
+430,602
| +106% | +$39.2M | 0.17% | 132 |
|
|
2023
Q2 | $65.7M | Buy |
405,706
+89,341
| +28% | +$14.5M | 0.15% | 151 |
|
|
2023
Q1 | $50.3M | Buy |
316,365
+247,445
| +359% | +$39.4M | 0.14% | 158 |
|
|
2022
Q4 | $9.33M | Buy |
+68,920
| New | +$9.33M | 0.03% | 378 |
|